Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Feasibility Study of Meso BioMatrix Device for Breast Reconstruction [NA]
Feasibility study update for the Meso BioMatrix device in breast reconstruction following breast cancer treatment; study completed with resu…
-
FDA approval · 2019-09-09FDA Approved: KISQALI — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for KISQALI (ribociclib) from Novartis, updating the label to include an additional breast cance…
-
FDA approval · 2019-09-09FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application to authorize a Kisqali-Femara co-pack containing ribociclib and letrozole.
-
FDA approval · 2019-09-09FDA Approved: IBRANCE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for IBRANCE (palbociclib) from Pfizer Laboratories Div Pfizer Inc, authorizing changes to its labeli…
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients [Phase 1, Phase 2]
Clinical trial update on dasatinib combined with trastuzumab and paclitaxel in first-line HER2-positive metastatic breast cancer (Phase 1/2;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer
A completed clinical trial assessing echocardiographic changes during adjuvant therapy in Hispanic women with HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Automated Breast Ultrasound Case Collection Registry
A clinical trial registry entry for an automated breast ultrasound case collection registry related to breast cancer has been terminated, wi…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer [Phase 3]
Phase IIIb trial evaluating safety and tolerability of Herceptin SC with Perjeta and docetaxel in HER2-positive advanced breast cancer has c…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating doxycycline in combination with bone-targeted therapy for patients with metastatic breast cancer, c…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia [Phase 4]
Phase 4 trial updating administration schedules of G-CSF (Filgrastim) for primary prophylaxis of febrile neutropenia in early stage breast c…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach [Phase 1]
Phase 1 trial update focusing on patient-centered decision making for breast reconstruction after mastectomy in breast cancer patients; resu…
-
CLINICAL_TRIALS withdrawal · 2019-09-06Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer [Phase 4]
A Phase 4 trial of abemaciclib in HR+, HER2- advanced/metastatic breast cancer has been withdrawn.
-
FDA approval · 2019-09-05FDA Approved: DOCETAXEL — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for docetaxel (docetaxel anhydrous) by Mylan Institutional LLC under ANDA 210072.
-
FDA approval · 2019-09-05FDA Approved: ANASTROZOLE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Anastrozole from Zydus Lifesciences Limited. The document concerns the approval of a generic ver…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms [Phase 3]
Phase 3 clinical trial evaluating internet-based cognitive behavioral therapy for climacteric symptoms in breast cancer survivors has comple…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating Doxorubicin, Cyclophosphamide, and Paclitaxel with or without Bevacizumab in patients with lymph node-positive or h…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer [Phase 4]
Phase 4 clinical trial update evaluating MK-0752 in combination with tamoxifen or letrozole for early-stage breast cancer has completed; res…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. [Phase 2]
Phase 2 Neoadjuvant trial evaluating a fixed-dose combination with melatonin or metformin for locally advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial investigating neoadjuvant toremifene with melatonin or metformin in locally advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Open Label Immunotherapy Trial for Breast Cancer [Phase 2]
Open-label Phase 2 immunotherapy trial for breast cancer undergoing ongoing updates.
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: COGNUTRIN in Breast Cancer Survivors [EARLY_Phase 1]
Early-phase clinical trial update for COGNUTRIN in breast cancer survivors; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer [Phase 3]
Phase 3 trial comparing vinflunine plus gemcitabine to paclitaxel plus gemcitabine in advanced breast cancer was terminated with posted resu…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. [Phase 3]
Phase III trial evaluating bisphosphonates as adjuvant therapy in primary breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: RCT of an Internet-based CBT Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer [Phase 3]
A Phase 3 randomized trial evaluated an internet-based CBT program addressing sexuality and intimacy issues in women treated for breast canc…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression [Phase 1]
Phase 1 study of ADCT-502 in HER2-expressing advanced solid tumors including breast cancer and non-small cell lung cancer has terminated wit…